Lupin falls on getting 3 observations from USFDA for Aurangabad facility

16 May 2019 Evaluate

Lupin is currently trading at Rs. 772.00, down by 11.10 points or 1.42% from its previous closing of Rs. 783.10 on the BSE.

The scrip opened at Rs. 771.90 and has touched a high and low of Rs. 779.20 and Rs. 736.10 respectively. So far 444555 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 986.00 on 10-Sep-2018 and a 52 week low of Rs. 720.40 on 28-Mar-2019.

Last one week high and low of the scrip stood at Rs. 866.00 and Rs. 736.10 respectively. The current market cap of the company is Rs. 34918.35 crore.

The promoters holding in the company stood at 46.97%, while Institutions and Non-Institutions held 38.07% and 14.96% respectively.

The United States Food and Drug Administration (USFDA) has completed inspection at Lupin’s Aurangabad manufacturing facility. The inspection was carried out from May 6 to May 15, 2019.

The inspection at the Aurangabad facility closed with three observations. The company is confident of addressing them satisfactorily.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2189.75 8.30 (0.38%)
12-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1736.85
Dr. Reddys Lab 1215.65
Cipla 1466.05
Zydus Lifesciences 895.00
Lupin 2189.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×